Pediatric Vaccine Market Size, Share, And Growth Report 2032

Pediatric Vaccine Market: Size

The global Pediatric Vaccine Market size was worth around USD 19.80 billion in 2023 and is predicted to grow to around USD 36.10 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.9% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Pediatric Vaccine Market on a global and regional level.

Request Free Sample

Pediatric Vaccine Market: Overview

Vaccines provide protection against various diseases in the form of toxins or proteins. Vaccines are responsible for improving one’s immunity. Immunization is vital for the global health market and is an essential part of medicine. There are several immunization programs for children organized across several nations, but they may vary depending on the region. For instance, developed countries have specific primary immunization schedules. These immunizations schedules based on a child’s health, vaccine type, geographical area, and the vaccines available in that area. Vaccines are administered for different types of diseases like Hepatitis B, tetanus, influenza, chickenpox, measles, mumps, etc. These schedules are recommended by various agencies, such as the CDC, American Academy of Family Physicians, and the American Academy of Pediatrics. When weakened disease germs in the vaccine attack the immune system, the immune system sends antibodies to fight these germs and prevents the system from acquiring the disease if exposed to it in the future.

The global pediatric vaccine market is driven by increasing geriatric base, rising prevalence of infectious diseases, and growing disposable income of the global population. The rising number of immunization programs globally and the increasing awareness about the importance of preventive care during childhood are also fuelling this market. Various governments are taking initiative to increase the importance of vaccine development and leading companies are sponsoring R&D programs to enhance vaccine development for rare diseases. For example, government initiatives like the Vaccines for Children Program organize vaccination drives for children who cannot afford vaccines or do not have health insurance. However, the high vaccine cost may restrain the market growth in the future.

Request Free Sample

Pediatric Vaccine Market: Segmentation

The study provides a crucial view of the pediatric vaccine market by segmenting it based on the vaccine type, disease type, technology, administration method, end-user, and region. All the segments of the pediatric vaccine market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By vaccine type, the market includes monovalent and multivalent vaccines. Monovalent vaccines develop a rapid immune response and are more stable than multivalent vaccines. Multivalent vaccines are showing improved growth due to the development of tetravalent, hexavalent, and pentavalent vaccines.

Based on technology,  the market comprises recombinant vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, and live attenuated vaccines. Conjugate vaccines have the maximum demand, due to the rising incidences of meningococcal and pneumococcal infections.

The disease type segment consists of dengue, pneumococcal disease, hepatitis, MMR (measles, mumps, and rubella), varicella, polio, influenza, DTP, herpes zoster, rotavirus, human papilloma virus, meningococcal disease, and others.

The administration method segment of the pediatric vaccine market includes oral, subcutaneous, and intramuscular.

Hospitals, healthcare providers, and others are the various end-user of the pediatric vaccine market.

Pediatric Vaccine Market: Report Scope

Pediatric Vaccine Market: Regional Analysis

The regional segment comprises the current and forecast demand for the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe.

North America is witnessed to be a significant contributor to the pediatric vaccine market globally, due to the increasing number of hospitals, developing insurance sector, and favorable government regulations. The European pediatric vaccine market is growing owing to the ease of operability, efficient resource planning, presence of a large number of pharmaceutical companies, and rising government funding. All this makes facilitates quick and easy sourcing of vaccines. The Asia Pacific pediatric vaccine market will register the highest CAGR in the future, owing to the rapidly growing pediatric vaccine demand in India and Singapore.

Pediatric Vaccine Market: Competitive Players

Some key players operating in the global pediatric vaccine market are:

• Mitsubishi Tanabe Pharma
• Astellas Pharma
• Johnson & Johnson
• Pfizer
• CSL Limited
• GlaxoSmithKline
• Serum Institute of India
• Panacea Biotec
• Daiichi Sankyo
• Merck

The Global Pediatric Vaccine Market is segmented as follows:

Global Pediatric Vaccine Market: By Vaccine Type

• Monovalent Vaccines
• Multivalent Vaccines

Global Pediatric Vaccine Market: By Disease Type

• Meningococcal Disease
• Hepatitis
• Influenza
• Polio
• Pneumococcal Disease
• DTP
• MMR (Measles, Mumps, and Rubella)
• Dengue
• Rotavirus
• Human Papilloma Virus (HPV)
• Varicella
• Herpes Zoster
• Others

Global Pediatric Vaccine Market: By Technology

• Recombinant Vaccines
• Inactivated Vaccines
• Conjugate Vaccines
• Toxoid Vaccines
• Live Attenuated Vaccines

Global Pediatric Vaccine Market: By Administration Method

• Oral
• Intramuscular
• Subcutaneous

Global Pediatric Vaccine Market: By End-User

• Hospitals
• Healthcare Providers
• Others

Global Pediatric Vaccine Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa